EU Set to Revise Growth and Inflation Forecasts Amid Iran Conflict Stagflationary Shock Casper Network Unveils MultiYear Roadmap Targeting Regulated RealWorld Assets and Machine Economy CapCity Bank CCBG Slips 176 Testing 4306 Support 20260515 Frost Bank CFR Q1 2026 Earnings Why the Beat Matters Sprout Social SPT Q1 2026 Earnings Outperformance Signals Momentum EIKN Q1 2026 Earnings EPS Misses Estimates as Development Stage Company Continues RD Investment Workday Accelerates India Expansion and AI Investments as Global Capability Centres Surge NovaBay Pharmaceuticals NBY Q1 2026 Earnings No Surprises But Whats Next Ferrari Shares Slip as First Electric Model Luce Sparks Social Media Debate APEC Meeting Highlights Persistent USChina Trade Divergence After TrumpXi Summit April Jobs Report Expected to Show Cooling Yet Resilient Labor Market Ajmera Realty Shares Surge Nearly 10 on Strong FY26 Results Sets Ambitious FY27 PreSales Target HNB General Insurance Appoints Dilshan Perera as Chief Operating Officer CBS Cancels The Late Show with Stephen Colbert Networks LateNight Strategy Shifts to Comics Unleashed MTR Q4 2025 Earnings Trust Reports 004 Per Unit Stock Gains 154 Embecta Corp EMBC Q1 2026 Earnings EPS Misses Expectations as Revenue Data Remains Unavailable Soleno Therapeutics Q1 2026 Earnings EPS Misses Estimates by 1494 Stock Holds Steady JACK Q1 2026 Earnings EPS Misses by a Hair as Stock Rises 176 EXTR Q1 2026 Earnings EPS Surpasses Estimates Shares Rally Over 7 HALO Q1 2026 Earnings EPS Surpasses Estimates Despite Revenue Discretion Melar Acquisition Corp I Warrant MACIW Holds Near Support Amidst Low Volume Trading Belden Inc BDC Faces Selling Pressure Tests Key Support Near 102 Veracyte Shares Dip as Biotech Sector Faces Headwinds Key Support Tested Raytech Holding RAY Edges Higher as Shares Test Key Resistance Zone Insight Digital Partners II DYOR Edges Higher Near Resistance on Minimal Price Action Alibaba BABA Receives Price Target Boost to 185 from Susquehanna OFS Capital Corporation OFS Q1 2026 Earnings Massive EPS Beat Driven by Strong Net Investment Income Inhibikase Therapeutics IKT Faces Selling Pressure as Stock Retreats to 169